Disclosure 0001835966-26-000008-5

SEC FORM 4

$244,484.97

Revolution Medicines, Inc. (RVMD)

Sale of 1,199 shares at $203.9074 per share.

Reporting Person Sandler Alan B. · Officer Title Chief Development Officer · Transaction Code S

Traded Sep 29, 2026 · Disclosed Oct 1, 2026

Source: SEC Form 4 · 0001835966-26-000008 · filed 2026-10-01 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Revolution Medicines, Inc. (RVMD)." Disclosed 2026-10-01. https://desqlong.com/cards/0001835966-26-000008-5 (retrieved 2026-10-02).